Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Down 23.7% in October

Autonomix Medical, Inc. (NASDAQ:AMIX - Get Free Report) was the recipient of a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 136,100 shares, a decline of 23.7% from the September 30th total of 178,400 shares. Based on an average trading volume of 420,800 shares, the short-interest ratio is currently 0.3 days. Currently, 1.1% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, LADENBURG THALM/SH SH assumed coverage on Autonomix Medical in a research report on Tuesday, September 3rd. They issued a "buy" rating and a $1.40 target price on the stock.

Autonomix Medical Stock Performance

Autonomix Medical stock traded down $2.19 during midday trading on Friday, reaching $7.71. The company's stock had a trading volume of 137,513 shares, compared to its average volume of 84,444. Autonomix Medical has a 52 week low of $7.51 and a 52 week high of $152.00. The company has a debt-to-equity ratio of 0.20, a quick ratio of 9.27 and a current ratio of 9.27. The business has a 50-day moving average price of $0.79 and a 200-day moving average price of $1.42.

Autonomix Medical (NASDAQ:AMIX - Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. Analysts expect that Autonomix Medical will post -0.5 EPS for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.